Asscheman, A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. (2011)

My note: As a generalization, the longer the follow-up on transitioned individuals, the greater the risks and worse the outcomes. This is recognized in the literature, but only rarely by trans-advocates.